Biomedical Engineering Reference
In-Depth Information
therapeutic agents. 2. Cationic peptide vectors for brain delivery,” Chemotherapy,
53, pp. 73-76.
212. Rapoport, N., Marin, A.P., Timoshin, A.A., 2000, “Effect of a polymeric
surfactant on electron transport in HL-60 cells,” Arch. Biochem. Biophys.,
384, pp. 100-108.
213. Santra, S., Yang, H., Holloway, P.H., Stanley, J.T., Mericle, R.A., 2005,
“Synthesis of waterdispersible fluorescent, radio-opaque, and paramagnetic
CdS:Mn/ZnS quantum dots: a multifunctional probe for bioimaging,” J. Am.
Chem. Soc., 127, pp. 1656-1657.
214. Liu, L., Venkatraman, S.S., Yang, Y.Y., Guo, K., Lu, J. et al., 2008, “Polymeric
micelles anchored with TAT for delivery of antibiotics across the blood-brain
barrier,” Biopolymers, 90, pp. 617-623.
215. Qin, Y., Chen, H., Yuan, W., Kuai, R., Zhang, Q., et al., 2011, “Liposome
formulated with TAT-modified cholesterol for enhancing the brain delivery,”
Int. J. Pharm., 420, pp. 304-312.
216. Kabanov, A.V., Batrakova, E.V., Miller, D.V., 2003, “Pluronic block copolymers
as modulators of drug efflux transporter activity in the blood-brain barrier,”
Adv. Drug Deliv. Rev., 55, pp. 151-164.
217. Batrakova, E.V., Li, S., Alakhov, V.Y., Elmquist, W.F., Miller, D.W., Kabanov,
A.V., 2003, “Sensitization of cells overexpressing multidrug resistant protein
by Pluronic P85,” Pharm. Res., 20, pp. 1581-1590.
218. Qin, J., Chen, D., Hu, H., Cui, Q., Qiao, M., Chen, B., 2007, “Surface
modification of RGDliposomes for selective drug delivery to monocytes/
neutrophils in brain,” Chem. Pharm. Bull., 55, pp. 1192-1197.
219. Panyam, J., and Labhasetwar, V., 2003, “Dynamics of endocytosis and
exocytosis of poly(D, Llactide-co-glycolide) nanoparticles in vascular smooth
muscle cells,” Pharm. Res., 20, pp. 212-220.
220. Begley, D.J., 2004, “Delivery of therapeutic agents to the central nervous
system: the problems and the possibilities,” Pharmacol. Ther., 104, pp. 29-45.
221. Schulze, C., Smales, C., Rubin, L.L., Staddon, J.M., 1997, “Lysophosphatidic
acid increases tight junction permeability in cultured brain endothelial cells,” J.
Neurochem., 68, pp. 991-1000.
222. Monnaert, V., Betbeder, D., Fenart, L., Bricout, H., Lenfant, A.M., et al., 2004,
“Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport
of doxorubicin across an in vitro model of blood-brain barrier,” J. Pharmacol.
Exp. her, 311, pp. 1115-1120.
223. Tilloy, S., Monnaert, V., Fenart, L., Bricout, H., Cecchelli, R., Monflier, E.,
2006, “Methylated beta-cyclodextrin as P-gp modulators for deliverance of
doxorubicin across an in vitro model of blood-brain barrier,” Bioorg. Med.
Chem. Lett., 16, pp. 2154-2157.
224. Mackic, J.B., Stins, M., Jovanovic, S., Kim, K.S., Bartus, R.T., Zlokovic,
B.V., 1999, “Cereport (RMP-7) increases the permeability of human brain
microvascular endothelial cell monolayers,” Pharm. Res., 16, pp. 1360-1365.
225. Emerich, D.F., Snodgrass, P., Dean, R., Agostino, M., Hasler, B., et al., 1999,
“Enhanced delivery of carboplatin into brain tumours with intravenous
Cereport (RMP-7): dramatic differences and insight gained from dosing
parameters,” Br. J. Cancer, 80, pp. 964-970.
